Nonnucleoside Reverse Transcriptase Inhibitors
DBCAT003641Therapeutic category
A DrugBank category of 6 drugs. 6 of them are approved.
What you can answer from here — as of October 27, 2017
Which targets do Nonnucleoside Reverse Transcriptase Inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account